Discover

VTGN
Vistagen Therapeutics, Inc.
0.24
2 x 0.18
2 x 0.28
bid
ask
+
0.02
7.52%
2 @ 07:09 AM
0.24 -0.00 (0.86%)
Ytd-63.18%
1y-88.09%
0.21
day range
0.26
0.20
52 week range
5.14
Open0.22Prev Close0.23Low0.21High0.26Mkt Cap9.97M
Vol14.21MAvg Vol1.90MEPS-1.83P/EN/AForward P/E-1.49
Beta0.78Short Ratio1.69Inst. Own53.63%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg0.60200-d Avg1.731yr Est13.00

VTGN News

Vistagen Therapeutics, Inc. (VTGN) Discusses PALISADE-4 Phase III Results and Post-Hoc Analyses in Social Anxiety Disorder Transcript
seekingalpha.com
Vistagen Therapeutics, Inc. (VTGN) Discusses PALISADE-4 Phase III Results and Post-Hoc Analyses in S

Vistagen Therapeutics, Inc. (VTGN) Discusses PALISADE-4 Phase III Results and Post-Hoc Analyses in S

Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss
benzinga.com
Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss

Vistagen Inc. (NASDAQ:VTGN) on Monday reported that its Phase 3 PALISADE-4 trial of intranasal fased

Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss
benzinga.com
Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss

Vistagen's Phase 3 fasedienol trial missed its main endpoint, but the company found a severe-pat

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

Nasdaq Gains Over 300 Points; Chicago PMI Falls In June
benzinga.com
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June

US stocks traded higher, Nasdaq up 150 points. Dow up 0.02%, Nasdaq up 0.68%, S&P 500 up 0.28%.

US Stocks Mixed; Home Prices Increase 1.1% In April
benzinga.com
US Stocks Mixed; Home Prices Increase 1.1% In April

US stocks mixed, Dow falls 0.2%. Leading sectors: tech up 1%, real estate down 1.4%. S&P 500 up

benzinga.com
Vistagen Announces Topline Results From Its PALISADE-4 Phase 3 Trial Of Intranasal Fasedienol To Tre

PALISADE-4 was a U.S. multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical tr

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
businesswire.com
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biophar

benzinga.com
VistaGen Therapeutics Q4 EPS $(0.37) Misses $(0.30) Estimate, Sales $465.000K Beat $320.000K Estimat

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.37) per share which missed the

benzinga.com
Vistagen Announces Its Data From PALISADE-3 Phase 3 Trial Of Fasedienol Demonstrates Well-Toleration

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with

benzinga.com
Vistagen Completes Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fased

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with

benzinga.com
Vistagen Receives "Study May Proceed" Letter From FDA Under IND Application For Refisolone Nasal Spr

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints
benzinga.com
Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints

Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pr

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Applied Materials Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Applied Materials Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Vistagen Therapeutics Earnings Report: Q3 Overview
benzinga.com
Vistagen Therapeutics Earnings Report: Q3 Overview

benzinga.com
VistaGen Therapeutics Q3 EPS $(0.45) Misses $(0.44) Estimate, Sales $303.000K Miss $366.000K Estimat

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.45) per share which missed the

Earnings Scheduled For February 12, 2026
benzinga.com
Earnings Scheduled For February 12, 2026

benzinga.com
Jefferies Downgrades Vistagen Therapeutics to Hold, Lowers Price Target to $0.9

Jefferies analyst Andrew Tsai downgrades Vistagen Therapeutics (NASDAQ:VTGN) from Buy to Hold and

Vistagen's Social Anxiety Disorder Drug Disappoints In Pivotal Late-Stage Study
benzinga.com
Vistagen's Social Anxiety Disorder Drug Disappoints In Pivotal Late-Stage Study

Vistagen shares plunge after its Phase 3 fasedienol trial for social anxiety failed to meet the prim

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Crude Oil Rises Over 1%; General Mills Earnings Top Views
benzinga.com
Crude Oil Rises Over 1%; General Mills Earnings Top Views

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings
benzinga.com
Dow Jumps 150 Points; Jabil Posts Upbeat Earnings

benzinga.com
Vistagen Says PALISADE-3 Phase 3 Study Of Intranasal Fasedienol For Acute Treatment Of Social Anxiet

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in

benzinga.com
Vistagen Presents Data Showing PH80's Potential As Rapid Intranasal Treatment For Menopause Hot Flas

Research supports the product candidate's non-hormonal, non-systemic, rapidly-acting effects on

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
VistaGen Therapeutics Q2 EPS $(0.54) Misses $(0.48) Estimate, Sales $258.000K Beat $243.333K Estimat

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.54) per share which missed the

Earnings Scheduled For November 13, 2025
benzinga.com
Earnings Scheduled For November 13, 2025

Examining the Future: VistaGen Therapeutics's Earnings Outlook
benzinga.com
Examining the Future: VistaGen Therapeutics's Earnings Outlook

benzinga.com
Vistagen Last Patient In PALISADE-3 Phase 3 Study Completes Trial For Evaluation Of Fasedienol To Tr

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience wit

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For June 17, 2025

benzinga.com
Earnings Scheduled For February 13, 2025

benzinga.com
Earnings Scheduled For February 13, 2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the compan

benzinga.com
Earnings Scheduled For August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mi

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Tech

benzinga.com
Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on W

benzinga.com
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday

Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company

benzinga.com
Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursda

benzinga.com
Why Alteryx Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Gainers

benzinga.com
Earnings Scheduled For February 7, 2023

Companies Reporting Before The Bell • BP (NYSE:BP) is likely to report quarterly earnings at $1.67

benzinga.com
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co

benzinga.com
Earnings Scheduled For November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 838 companies hit new 52-week lows.

benzinga.com
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

benzinga.com
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Se

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatil